Company: XOMAP
Filing Date: 2025-12-05
Form Type: 8-K
Source: 0001193125-25-308794
Chunk: 3

Company: XOMA Royalty Corp
Filing Date: 2025-12-05
Form: 8-K
Item: Item 8.01
Chunk 3
---
a Financial Information.

The unaudited pro forma condensed combined financial information of XOMA and Mural as of and for the nine months ended September 30, 2025 and the year ended December 31, 2024 and the related notes will be included in an exhibit that will be filed in an amendment to this Current Report on Form 8-Kwithin the period specified in Item 9.01(a)(3) of Form 8-K.

(d)  Exhibits.

  Exhibit No.      Description                                                                                                                 
          2.1      Transaction Agreement, by and among XOMA Royalty Corporation, XRA 5 Corp. and Mural Oncology plc, dated August 20, 2025. *  
         99.1      Press Release issued by XOMA Royalty Corporation on December 5, 2025.                                                       
 ───────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
          104      Cover Page Interactive Data File (embedded within the Inline XBRL document).                                                

  Certain exhibits, annexes and schedules have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The Company hereby undertakes to furnish supplemental copies of any of the omitted exhibi...